MET and neoplasm: Our analysis demonstrated that patients with a combined high expression of HGFR and HER2/neu, EGFR, IGF1R, Mucin-1 and Integrin α2β1 show a very aggressive tumor biology with an impaired median survival compared to HGFR high-expressing tumors alone.